Pursuant
to Rule 477(a) promulgated under the Securities Act of 1933, as amended,
Hemcure, Inc. (the “Company”) hereby requests the withdrawal, effective as of
the date hereof, of the amendment to the Company’s registration statement on
Form SB-2, File No. 333-144861, together with all exhibits thereto (the
“Amendment”).
The
Company requests withdrawal of the Amendment because it was inadvertently filed
as a pre-effective amendment rather than as a post-effective
amendment.
If
you
have any questions or comments or require further information or documentation,
please do not hesitate to contact Mary Ann Sapone of Richardson & Patel LLP,
the Company’s outside counsel, at (707) 937-2059.
Respectfully
submitted,
HEMCURE,
INC.
By: /s/
Arthur Liu
Arthur
Liu, Chief Executive Officer
Dates Referenced Herein and Documents Incorporated by Reference
